National Comprehensive Cancer Network

Program Overview:
Pharmaceutical and biotechnology professionals are given the significant opportunity to view the oncology space, its future and its current operational issues from the provider and payor perspective. Participants will improve their working knowledge of key business, policy, coverage, reimbursement, informational, and operational issues in oncology and will gather valuable insights into developing effective strategies for navigating the various constituencies in cancer care.

Through this interactive program, pharmaceutical and biotech professionals will learn from key stakeholders what they view to be the most pressing issues in oncology today and how to apply this knowledge to create mutually-successful working relationships. Further, they will hear thought leaders discuss how their decisions and programs are shaped by certain types of information and data.

Intended Audience:
Professionals from marketing, sales, medical affairs, clinical research, policy and government affairs, and other business areas will be able to better serve their customers with improved knowledge of real-world oncology issues after completion of this program.

“One of the most comprehensive, interesting, entertaining, and engaging ‘capsule’ overview of the admittedly highly complex subject matter” – NCCN Academy Attendee

Working Program Agenda*:

7:30 – 8:30 AM	Registration and Breakfast
8:30 – 8:35 AM	Welcome William T. McGivney, PhD National Comprehensive Cancer Network
8:40 – 10:10 AM	Module I: Real World Trends Impacting Cancer Care – Cost, Reimbursement, and Policy Peter B. Bach, MD, MAPP Memorial Sloan-Kettering Cancer Center Lee N. Newcomer, MD, MHA UnitedHealthcare Kavita Patel, MD, MSHS New America Foundation Steve E. Phurrough, MD, MPA Center for Medical Technology Policy
10:10 – 10:30 AM	Break
10:30 – 11:45 AM	Module II: Guidelines Pathways and the IT Superhighway: Impact on Drugs and Biologics Utilization Lida Andrews, PharmD CVS Caremark Ephraim P. Hochberg, MD Massachusetts General Hospital Cancer Center Michael Kolodziej, MD Innovent Oncology Ed Pezalla, MD, MPH Aetna Inc.
11:45 AM – 12:45 PM	Lunch
12:45 – 2:00 PM	Module III: Information Needs and Investment Decisions on Wall Street Jeff Chaffkin, CFA Charter Oak Partners James Dougherty, MD, MBA Arcus Ventures Douglas D. Lind, MD GBP Capital Management Cynthia Schwalm Consulting with Cynthia Schwalm; formerly President at Eisai; Vice President, GM Oncology at Amgen
2:00 – 2:20 PM	Break
2:20 – 3:50 PM	Module IV: Meet the Experts: NCCN Guidelines Panel Chairs Address Hot Topics and Your Burning Questions Al B. Benson, MD Robert H. Lurie Comprehensive Cancer Center of Northwestern University Jeffrey Crawford, MD Duke Cancer Institute Susan O’Brien, MD The University of Texas MD Anderson Cancer Center Andrew D. Zelenetz, MD, PhD Memorial Sloan-Kettering Cancer Center
3:55 – 4:00 PM	Closing Remarks William T. McGivney, PhD National Comprehensive Cancer Network
4:00 – 6:00 PM	Networking Reception

*Faculty and agenda are subject to change.

Tuition:

	Before 9.15.2010	After 9.15.2010
Regular Rate	$1,195	$1,295
NCCN Corporate Council Members	$1,095	$1,195
NCCN Academy Alumni	$795	$895
Group rate (per attendee for companies sending 10 or more attendees)	$1,050

Tuition includes lunch on Thursday. All participants are encouraged to attend the networking reception at the conclusion of the program from 4:00 – 6:00 PM on Thursday, October 7, 2010.

Recommended attire for the NCCN Academy is business casual. Program handouts will be provided for reference and note-taking.

If you register for the program and then cannot attend, a substitute attendee may be sent in your place. A $50 administration fee will be charged for each substitution. A $50 administration fee will be charged for cancellations received through September 15, 2010. After September 15, the registration fee is not refundable.

Enroll now to secure a seat at this program.